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Interpersonal problems and affective dysregulation are core characteristics of borderline
personality disorder (BPD). BPD patients predominantly show unresolved attachment
representations. The oxytocin (OT) system is associated with human social attachment
and affiliative behavior, and OT dysregulation may be related to distinct attachment
characteristics. Here, we investigated whether attachment representations are related
to peripheral OT levels in BPD patients. Twenty-one female BPD patients and 20 age-,
gender-, and education-matched healthy controls (HCs) were assessed with clinical
scales and measures of interpersonal and attachment-related characteristics, including
the Adult Attachment Projective Picture System (AAP). Plasma OT concentrations were
measured prior to and during social exclusion in a virtual ball tossing game (Cyberball).
The majority of BPD patients (63.2%) but no HCs showed unresolved (disorganized)
attachment representations. In this subgroup of patients, baseline OT plasma levels
were significantly lower than in BPD patients with organized attachment representations.
This pilot study extends previous findings of altered OT regulation in BPD as a putative
key mechanism underlying interpersonal dysregulation. Our results provide first evidence
that altered OT plasma levels are related to disorganized attachment representations in
BPD patients.
Keywords: oxytocin, attachment representation, borderline personality disorder, social exclusion, cyberball,
social pain
INTRODUCTION
Borderline personality disorder is characterized by a pervasive pattern of emotional instability,
impulsivity, severe problems in social interactions, and disturbed self-image (Bohus et al., 2009;
Leichsenring et al., 2011). Particularly dysfunctional interpersonal beliefs and behavior, such
as interpersonal events like rejection or exclusion, have a high clinical relevance and result in
Abbreviations: AAI, Adult Attachment Interview; AAP, Adult Attachment Projective Picture System; BDI-II, Beck
Depression Inventory; BPD, Borderline personality disorder; BSL-23, Borderline-Symptom-List-23; CSF, cerebrospinal fluid;
CTQ, Childhood Trauma Questionnaire; CV, interassay coefficient of variation; HAMD-24, Hamilton Depression Rating
Scale; HC, healthy controls; NTQ, Needs-Threat-Questionnaire; OT, Oxytocin; RSQ, Rejection Sensitivity Questionnaire;
SCID, Structural Clinical Interview for DSM-IV; SGA, second-generation antipsychotics; TSST, Trier Social Stress Test.
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increasing aversive tension in BPD, which may lead to self-
injurious behavior or dissociation (Herpertz, 1995; Stiglmayr
et al., 2005; Gunderson and Lyons-Ruth, 2008). Interpersonal
styles of BPD patients are characterized by a need for
closeness and attention, combined with a fear of rejection and
abandonment. Winter et al. (2015) found a negative evaluation
bias for positive, self-referential information in BPD patients
suggesting that they tend to refer information to themselves
even if no explicit reference context is set. At the same
time, BPD patients demonstrate significant impairments in
making social judgments about others from their faces by
judging them as less trustworthy and approachable than controls
(Nicol et al., 2013). Moreover, Fertuck et al. (2009) reported
an enhanced mental state discrimination based on the eye
region of the face in BPD patients compared to HCs and
considered this enhanced sensitivity as a potential basis for social
impairment in BPD. Gunderson and Lyons-Ruth (2008) describe
a genetically based hypersensitivity to interpersonal stressors in
BPD patients: An interpersonal hypersensitivity phenotype may
lead to characteristic interpersonal strategies and contradictory
interpersonal features observed in adult BPD patients.
Stanley and Siever (2010) suggested that an altered regulation
within the OT system might be an underlying mechanism for this
interpersonal dysregulation in BPD, which might have developed
because of or been enforced by adverse caretaking experiences
in early childhood. Adverse early caretaking experiences,
such as maltreatment, abuse, emotional neglect, separation,
inconsistency, and invalidation, are thought to disrupt
interpersonal attachment, leading to distinct attachment patterns
(e.g., Lyons-Ruth and Jacobvitz, 2008). Current attachment
representations of early experience can be assessed in adulthood
by semi-structured interviews (Ravitz et al., 2010). These
narrative assessments are typically used to divide individuals into
groups with regard to representational security or insecurity,
including individuals who are unresolved with regard to loss or
physical or sexual abuse. More than 90% of adult BPD patients
show insecure attachment classifications, and a high frequency
of unresolved attachment representations predominates in some
samples (Barone, 2003; Agrawal et al., 2004; Levy et al., 2006;
Gunderson and Lyons-Ruth, 2008; Bakermans-Kranenburg and
van IJzendoorn, 2009). Unresolved attachment, therefore, is of
special importance in the development of BPD (Lyons-Ruth and
Jacobvitz, 2008; Buchheim and George, 2011).
The neuropeptide OT has been hypothesized to play a crucial
role in attachment, because it is involved in the regulation
of human social behaviors such as mother-infant interaction,
pair bonding, affiliative behavior, trust, and trustworthiness
(Macdonald and Macdonald, 2010; Meyer-Lindenberg et al.,
2011; Feldman, 2012). Intranasal administration of OT in
healthy participants leads to enhanced theory of mind capacity,
perception of attachment security, and relational trust and
reduction of social stress (Kirsch et al., 2005; Kosfeld et al.,
2005; Domes et al., 2007; Heinrichs and Domes, 2008; Buchheim
et al., 2009; Zhong et al., 2012; Kumsta and Heinrichs, 2013). In
BPD, OT dysregulation has been hypothesized to be one major
neurobiological mechanism underlying interpersonal problems
and hypersensitivity to social cues (Stanley and Siever, 2010;
Meyer-Lindenberg et al., 2011). Intranasal OT was found to have
stress-attenuating effects (reduced cortisol levels and reduced
dysphoric mood) in 14 BPD patients during the TSST (Simeon
et al., 2011). In neuroeconomic game paradigms, however, OT
was found to exert different effects in BPD patients than in
healthy participants, i.e., intranasal OT administration reduced
trust and cooperation in 14 (four males) BPD patients and
interpersonal trust in 13 (five males) BPD patients compared
to HCs (Bartz et al., 2011; Ebert et al., 2013). These findings
support the notion that sensitivity to social cues may be increased
by OT, but the interpretation of these cues might be influenced
by contextual (i.e., presence of a stranger versus friend) or
individual (i.e., gender, attachment patterns, or the presence of
psychiatric symptoms) factors (Olff et al., 2013). This might also
be reflected in fewer prosocial behaviors in a study of non-
verbal communicative signals in BDP during social interaction
after OT administration (Brüne et al., 2015). However, another
study showed that intranasal OT administration decreased the
hypersensitivity to social threat in 40 female BPD patients, as
measured by patterns of reflexive eye movements toward angry
and fearful faces, and normalized amygdala activity (Bertsch
et al., 2013). In addition, a recent study demonstrated that OT
administration abolished the avoidant reaction to angry faces
in 13 (five males) BPD (Brüne et al., 2013). Taken together,
OT research is inconclusive and according to Brüne (2015) it
seems oversimplified to render BPD an OT deficit syndrome
(Stanley and Siever, 2010). Moreover it is still unclear whether
OT should be used therapeutically as an add-on treatment in
BPD patients (Eckstein and Hurlemann, 2013; Brüne, 2015).
Inconsistent study results and effects of OT in BPD might be
explained by inhomogenity and limitations of previous studies
including mixed-sex and small size of samples as well as missing
control for mestrual cycle in some cases.
Adverse attachment events during childhood, such as physical
and sexual abuse by a significant caretaker, contribute to
the development of BPD (Leichsenring et al., 2011), and
maltreatment has been shown to be associated with altered
OT regulation in children (Seltzer et al., 2014). The first study
investigating OT plasma concentrations in 34 female BPD
patients found lower plasma levels in patients than in HCs;
levels were associated with childhood traumatization (Bertsch
et al., 2012). A recent study by Jobst et al. (2014) showed lower
OT plasma levels in 22 female BPD patients than in healthy
individuals in response to a social exclusion situation, which
constitutes a strong negative bonding stimulus in BPD (Jobst
et al., 2014). These results converge with previous findings of an
impaired social repair function in BPD when social cooperation
is broken (King-Casas et al., 2008). The hypothesis of an altered
regulation of endogenous OT in BPD is further supported by
links to traumatic lifetime experiences: OT CSF levels of 22
women with childhood traumatization were negatively associated
with trauma in a study categorizing participants into those
with none-mild versus those with moderate-severe exposure
to various forms of childhood abuse or neglect. The authors
found inverse associations between CSF OT concentrations and
both the number of exposure categories and the severity and
duration of the abuse (Heim et al., 2009). Pierrehumbert et al.
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(2010) found a positive correlation between OT release after a
social stress situation (TSST) and childhood trauma in a mixed-
sex sample. The study included participants with sexual abuse
in childhood or adolescence as well as survivors of cancer in
childhood or adolescence and a control group. Participants with a
life-threatening illness during childhood showed higher OT levels
than both abused and healthy participants (Pierrehumbert et al.,
2010).
Several studies have focused on the link between affiliative
behavior, attachment, and OT (Feldman, 2012; Stoesz et al.,
2013). Studies on the role of OT for bonding difficulties report
evidence of an effect of OT on human affiliation, because
they observed that OT plasma levels across pregnancy and the
postpartum period predicted mother–infant bonding (Feldman
et al., 2007; Eapen et al., 2014). Moreover, intranasal OT
administration increased the subjective experience of attachment
security in 26 healthy male participants with insecure attachment
representations (Buchheim et al., 2009), and adult attachment
representations predicted OT and cortisol response to stress in
both individuals with (n = 46) and those without (n = 28)
childhood trauma (Pierrehumbert et al., 2012). Participants
with preoccupied attachment showed low OT levels after the
stress situation, whereas participants with unresolved attachment
showed intermediate OT levels (Pierrehumbert et al., 2012).
A recent pilot study (n = 14) used film clips of bonding
or abandonment scenes to investigate OT plasma levels as a
potential biomarker for alterations in the female attachment
system. While lower OT plasma levels during abandonment
scenes were positively correlated with posttraumatic stress
symptoms, higher OT plasma levels during bonding scenes were
negatively correlated with scores of dissociation and somatization
(Munro et al., 2013).
To our knowledge, there is no study published investigating
the association between attachment patterns in BPD patients and
OT plasma concentrations. As the first analysis of our study was
mainly focusing on differences in changes of peripheral OT levels
after social exclusion between BPD patients and HCs (Jobst et al.,
2014) irrespective of attachment representations, we re-analyzed
our data here including the results of the AAP, a reliable and
valid measure of adult attachment representations (George et al.,
1999; George and West, 2011, 2012). We investigated attachment
patterns in relation to both, general OT levels and their change
during a social exclusion situation comparing BPD patients and
HC. We hypothesized that alterations of OT levels observed
in BPD patients would be especially pronounced in patients
classified as unresolved, because this group is most frequently
and seriously affected by early attachment trauma (Stalker
and Davies, 1995; Bakermans-Kranenburg and van IJzendoorn,
2009) potentially disrupting a physiological development of OT
regulation.
MATERIALS AND METHODS
Participants
Twenty-two female patients aged 19 to 46 years (M = 30.0 years,
SD = 7.95) diagnosed with BPD and 21 HC aged 19 to
50 years (M = 29.71, SD = 10.26) matched for gender, age,
and education participated in this study. BPD patients (8
inpatients and 14 outpatients) were recruited at the Department
of Psychiatry and Psychotherapy at the Ludwig Maximilian
University, Munich. BPD diagnoses and comorbid axis I and
II diagnoses were assessed with the German Version of the
SCID (SCID-I screening, SCID-II interview; First et al., 1995).
Exclusion criteria were a comorbid diagnosis of substance
dependence, schizophrenia, schizoaffective disorder, or bipolar
disorder. All BPD patients met diagnostic criteria for BPD
according to DSM-IV criteria. Comorbid diagnoses on SCID-I
and -II were M = 3.50, SD = 1.68 (SCID-I: M = 0.91,
SD= 0.81; range 0–3; SCID-II: M = 2.59, SD= 1.44, range 0–5).
The following comorbid personality disorders were observed:
Avoidant (n = 11), depressive (n = 10), anankastic (n = 4),
negativistic (n = 4), paranoid (n = 4), dependent (n = 2), and
histrionic (n = 1). Other comorbidities were major depressive
disorder (n = 5) and eating disorder (n = 3). HC were recruited
by advertisements in newspapers and posters on noticeboards. In
HC, exclusion criteria were a current psychiatric disorder and a
psychiatric and psychological treatment in the past 10 years, as
confirmed with the SCID-I and -II screening instruments (First
et al., 1995).
Most BPD patients received pharmacological treatment, as
follows: Antidepressants (n = 15), SGA (n = 14), and mood
stabilizers (n = 8). At the time of assessment, seven patients
were taking sedative medication, and three patients were not
taking any psychopharmacological drugs. All BPD patients were
in current inpatient or outpatient psychotherapy.
The study was approved by the Institutional Review Board
of the Faculty of Medicine at the University of Munich. All
participants provided written informed consent. The study was
part of a larger study investigating changes of neuropeptides
during a social exclusion paradigm in patients with different
psychiatric diagnoses. The results presented here are an extension
of our previous study (Jobst et al., 2014).
Procedure and Measures
The experimental protocol included three separate sessions. At
the first session, a screening interview was conducted to check
for exclusion criteria, and participants were asked to provide
informed consent. Moreover, participants completed German
versions of a series of psychometric questionnaires: The BSL-23
(Bohus et al., 2009) to measure the severity of BPD symptoms; the
BDI-II (Beck et al., 1996), and the 24-item HAMD-24 (Hamilton,
1960) to measure the severity of depression; the emotional abuse,
emotional neglect, physical abuse, physical neglect, and sexual
abuse subscales of the CTQ (Bernstein et al., 2003; Klinitzke et al.,
2012), to assess traumatic experiences in childhood; and the RSQ
(Downey and Feldman, 1996) to check for the grade of sensitivity
to rejection.
At the second session, trained professionals at the Department
of Psychiatry and Psychotherapy, Ludwig Maximilian University,
Munich, administered the AAP (George et al., 1999; George
and West, 2011, 2012). Administration lasted about 30 min.
The AAP is a free-response measure comprising a set of eight
line drawing stimuli, one showing a neutral scene and seven
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showing attachment scenes (e.g., illness, separation, solitude,
death, and threat). Participants are asked to tell a story of what
led up to a scene, what the characters are thinking or feeling,
and what might happen next. Classifications are derived from
evaluating response patterns on several response dimensions
(agency of self, connectedness, synchrony, defensive processes)
by using verbatim transcripts of audiotaped responses to the
seven attachment-activating stimuli. The coding was performed
by independent, trained raters at the Department of Psychology
at the University of Innsbruck, Austria. Each participant was
assigned to one of the four attachment classification groups
“secure,” “dismissing,” “preoccupied,” or “unresolved.” The last
three groups represent different types of attachment insecurity.
Among these, unresolved representation is most frequently
associated with early attachment trauma (Stalker and Davies,
1995) and is assigned when the response material demonstrates
a failure to organize or contain representation indications of fear
and dysregulation. On the basis of this differentiation, we defined
two categorical pairs of representation types for comparison: (1)
Secure vs. insecure, and (2) organized (resolved) vs. unresolved
(disorganized). The psychometric properties of the AAP are
excellent (George and West, 2012). Interrater reliability was
found to be 90% (k = 0.85, p < 0.001, n = 144). Test–retest
reliability was calculated on the basis of 69 participants who
completed the AAP retest 3 months after the original AAP
administration; 58 (84%) were classified in the same attachment
group categories (k = 0.78, p < 0.001; 82% stability for secure,
96% stability for dismissing, 62% for preoccupied; 80% for
unresolved). Verbal intelligence and social desirability are not
related to AAP classifications (George and West, 2012). AAP
convergence of classifications with the AAI (George et al., 1985;
Main and Goldwyn, 1985–1994), the gold standard in the field
of adult attachment assessment, was 84% for the four-group
classification (k = 0.71, p < 0.001), 91% for the two-group
classification (k = 0.91, p < 0.001), and 88% for the unresolved-
resolved classification (k = 0.75, p < 0.001). The predictive
validity of the AAP has been established for both clinical and
healthy samples (Buchheim and George, 2011, 2012; George and
West, 2012).
At the third session, plasma samples were taken for OT
measurement before and after individuals participated in
a social exclusion paradigm (Cyberball) in a standardized
experimental setting, as previously reported (Jobst et al., 2014).
In brief, through-the-wall blood drawings were performed by
using a long catheter that ran through a soundproof lock
to an adjacent laboratory. Participants had no visual contact
with the investigators during the experiment. After baseline
measurements had been taken, the Cyberball game was started
on a computer screen positioned in front of the participants. The
Cyberball paradigm is a virtual ball-tossing game played with
two other virtual players and controlled by computer software
(Williams and Jarvis, 2006). Participants were shown a statement
on the computer screen that told them that they would take
part in this virtual game with two other real players. Participants
played one round of Cyberball, which lasted about three minutes.
Participants were thrown the ball three times (10% of the throws)
at the beginning of the round but were then excluded from the
game without explanation and were able only to watch the other
players.
During our study, we paid special attention to the stage
of participants’ menstrual cycle, because of neuroendocrine
interactions with OT. Participants taking hormonal
contraception were assessed during the 3rd and 18th day of
the intake period, and those not taking hormonal contraception
were assessed within the follicular phase, between the 5th and
12th day of the menstrual cycle, because gonadal hormones are
more stable during this period (Salonia et al., 2005). Participants
were told not to eat or drink one hour before hormonal
measurement. All measurements took place in the morning
between 8 and 11 a.m. to control for the circadian change in
hormones.
Blood samples for OT measurement were collected at four
time points: t0 (baseline), t1 (5 min after Cyberball), t2 (15 min
after Cyberball), and t3 (40 min after Cyberball). Storage tubes
were prepared in advance with aprotinin (500 IU/ml) in order
to prevent OT degradation. Afterward, blood samples were
centrifuged (1600g, 15 min), and plasma was stored at minus
80◦C until the biochemical analyses. Analysis of plasma OT was
performed by the Neurochemical Laboratory at the Department
of Psychiatry, Ludwig Maximilian University, Munich, with a
commercially available Enzyme Linked Immunosorbent Assay
(ELISA) Kit (Enzo Life Sciences, Germany). Measurements were
performed in duplicates. The inter-assay CV was below 17%,
and the intra-assay CV was 15%. To control for stress reactivity,
plasma cortisol was also measured; serum cortisol levels were
determined with an immunoassay analyzer (Elecsys Cortisol
Test; Roche Diagnostics, Mannheim, Germany), according to the
manufacturer’s instructions.
Emotional reactions to the social exclusion paradigm were
measured with self-rating questionnaires, the NTQ (Williams
et al., 2000), the Emotion Scale (Gross and Levenson, 1995)
before and after Cyberball, as previously reported (Jobst et al.,
2014). In addition, we asked the participants to assess aversive
inner tension, expressed as a percentage of maximal tension
before and after Cyberball.
Statistics
SPSS software version 17 was used for statistical analyses.
Demographic and psychometric analyses were performed with
χ2-tests and independent sample t-tests. To analyze outcomes
in the Cyberball paradigm, we used paired sample t-tests
for the NTQ and rmANOVA for the emotion scale. For
analysis of OT and cortisol levels as well as their changes
during Cyberball, three repeated measure analyses of variance
(rmANOVA) were conducted: (1) A group (HC vs. BPD)
× time (before vs. after) rmANOVA (as reported in Jobst
et al., 2014); (2) in BPD patients only a group (unresolved
vs. other) × time (before vs. after) rmANOVA; and (3) in
HC only a group (secure vs. insecure) × time (before vs.
after) rmANOVA. In case of violation of sphericity assumption,
Huynh–Feldt correction was used to present data. Moreover,
we applied post hoc independent sample t-tests. Baseline OT
plasma measurements showed a wide interindividual range
of 164.4 pg/ml to 5092.4 pg/ml. Two BPD patients and
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two HC were excluded from statistical analysis, because their
OT levels were higher than three standard deviations from
the mean of the whole sample (outliers between 1271.2 and
5092.4 pg/ml). Regarding attachment representations, data for 19
BPD patients and 18 HC were available and included into further
statistical analyses. Data samples for baseline OT showed normal
distribution (Kolmogorov–Smirnov test). Correlation analyses
were performed by Pearson correlation.
RESULTS
Demographic and Clinical
Characteristics
Borderline personality disorder patients and HC did not differ
significantly with regard to age and education. As expected,
BPD patients showed significantly higher scores than HC for
borderline and depressive symptoms (BSL-23, HAMD, and BDI-
II). Also as expected, the BPD group showed higher CTQ scores,
indicating early childhood trauma. On the basis of CTQ cut-off
values defined by Bernstein and Fink (1998), the BPD patients
in our sample reported moderate to severe traumatization. The
CTQ scores of the control group were below cut-off values on all
subscales. BPD patients also showed significantly higher scores of
rejection sensitivity than controls, as assessed by the RSQ. There
was no significant difference between BPD and HC as regards
menstrual cycle and hormonal contraception. For an overview
see Table 1.
Attachment, Clinical Variables, and Trauma
None of the BPD patients showed a secure attachment
representation, whereas 8 HC (44.4%) were classified as
secure. The attachment representations in the BPD group were
as follows: 12 (63.2%) unresolved (disorganized), 4 (21.1%)
dismissing, and 3 (15.8%) preoccupied, making a total of 36.8%
with organized representation (dismissing and preoccupied
together). Attachment representations among the HC were as
follows: 8 (44.4 %) secure, 6 (33.3%) dismissing, 4 (22.2%)
preoccupied, and none unresolved (disorganized). Secure and
unresolved (disorganized) attachment representation differed
significantly between BPD and HC (secure: χ2 = 10.77; df = 1;
p < 0.001; unresolved: χ2 = 16.83; df = 1; p < 0.001), whereas
dismissing and preoccupied representations did not (dismissing:
χ2 = 0.71; df = 1; p = 0.407; preoccupied: χ 2 = 0.25; df = 1;
p= 0.622).
The group of organized and unresolved (disorganized) BPS
patients showed no significant difference with regard to age,
education, menstrual cycle, contraception, borderline symptoms
(BSL-23), depressive symptoms (HAMD, BDI-II), and rejection
sensitivity (RSQ) (overview Table 2). According to CTQ cut-off
values, unresolved (disorganized) BPD patients reported severe
traumatization on all trauma subscales, whereas organized BPD
patients reported severe traumatization only on the subscales
emotional abuse, emotional neglect, and physical neglect and
mild traumatization on the subscales physical abuse and
sexual abuse. The differences in the last two subscales were
significant: On the physical abuse subscale, n = 5 (58.3%)
patients in the unresolved (disorganized) group showed severe
traumatization (cut-off score > 10) versus n = 2 (8.3%) in
the organized group (χ
2 = 10.67; df = 1; p < 0.001). On
the sexual abuse subscale, n = 3 (12.5%) patients in the
unresolved (disorganized) group showed severe traumatization
(cut-off score > 8) vs. n = 8 (66.7%) in the organized group
(χ
2 = 11.06; df = 1; p < 0.001). HC with secure and insecure
attachment representations did not differ with regard to age
or education. However, insecure HC scored significantly higher
on the HAMD (t = 2.649; df = 11.227; p = 0.022) than
secure HC.
OT and Cortisol Plasma Levels
Though plasma OT levels showed a marked inter-individual
variation, they were remarkably stable at an individual level.
Comparison of OT levels in BPD vs. HC
The rmANOVA comparing BPD patients and HC revealed
a significant group (BPD vs. HC) × time (before vs. after)
interaction when conducted over the first two time points
(F = 4.957; df = 1; p = 0.032; Figure 1) and no significant
group × time interaction when conducted over the four
time points (F = 1.467; df = 2.427; p = 0.234): OT levels
dropped after Cyberball from t0 to t1 in BPD whereas levels
increased in HC (post hoc independent sample t-test: t = 2.227;
df = 37; p = 0.032), as previously reported (Jobst et al.,
2014).
Comparison of OT levels in BPD patients with unresolved vs.
organized attachment patterns
As there were neither BPD patients with secure nor HCs with
unresolved attachment, unresolved vs. organized attachment
patterns were compared in BPD patients only and insecure vs.
secure attachment patterns in HC only. For BPD patients, the
respective rmANOVA showed a trend toward a significant group
effect between BPD patients with unresolved (disorganized)
and organized attachment (F = 3.679; df = 1; p = 0.073).
BPD patients with unresolved (disorganized) attachment
representations tended to show constantly lower OT levels
compared to HC. Post hoc independent sample t-test showed
significantly lower OT plasma concentrations at baseline in BPD
patients with unresolved (disorganized) attachment than in BPD
patients with an organized attachment representation (t = 2.346;
df = 17; p = 0.031, d = –1.078; see Figure 1). There was no
significant effect of time (before vs. after) in BPD (F = 1.647;
df = 3; p = 0.201), nor a significant group (unresolved vs.
organized) × time (before vs. after) interaction (F = 0.361;
df = 2.453; p = 0.742); both groups showed a similar course of
OT levels after social exclusion (Figure 1).
Comparison of OT levels in HC with insecure vs. secure
attachment patterns
The respective rmANOVA for HC showed neither a significant
effect of group (secure vs. insecure attachment pattern: F= 0.012;
df = 1; p = 0.916) nor of time (before vs. after: F = 0.587;
df = 3; p = 0.627) and no significant group × time interaction
(F = 0.450; df= 3; p= 0.718).
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TABLE 1 | Sample characteristics of patients with BPD and HC.
Characteristics BPD patients
(n = 20)
HC
(n = 19)
t-test p-value
Mean (SD)f
Age (in years) 29.85 (7.46) 30.42 (10.55) 0.20 0.847
Education (in years) 11.20 (1.70) 12.0 (1.53) 1.83 0.132
BSL-23a 2.07 (0.96) 0.08 (0.13) −9.18 <0.001
BDI-IIb 32.75 (14.28) 2.33 (3.0) −9.30 <0.001
HAMD-24c 29.90 (12.04) 1.28 (1.57) −10.20 <0.001
CTQd
Emotional abuse
Physical abuse
Sexual abuse
Emotional neglect
Physical neglect
Global
17.89 (4.98)
10.80 (7.16)
12.35 (8.39)
18.30 (5.19)
11.20 (4.4)
15.00 (4.86)
8.22 (6.26)
5.56 (1.34)
5.44 (2.20)
7.94 (3.95)
6.61 (2.59)
6.76 (2.35)
−3.19
−3.05
−3.39
−6.86
−3.96
−6.76
0.003
0.004
0.002
<0.001
<0.001
<0.001
RSQe 17.92 (5.45) 5.98 (2.82) −8.47 <0.001
Day of menstrual cycle
Hormonal contraception
9.83 (4.15)
5 (22.7%)
8.78 (3.62)
10 (47.6%)
−0.813
X2: 2.931
0.422
0.091
No significant differences between patient and control groups in age and education. aBSL-23, Borderline Symptom List; bBDI-II, Beck Depression Inventory; cHAMD-24,
Hamilton Depression Rating Scale; dCTQ, Childhood Trauma Questionnaire; eRSQ, Rejection Sensitivity Questionnaire; fSD, standard deviation.
TABLE 2 | Sample characteristics of BPD patients with organized or disorganized attachment representation.
Characteristics Organized
(n = 7)
Unresolved
(n = 12)
t-test p-value
Mean (SD)f
Age (in years) 25.14 (4.85) 31.75 (7.49) −2.08 0.053
Education (in years) 12.0 (1.73) 10.83 (1.64) 1.47 0.161
BSL-23a 1.74 (1.09) 2.05 (1.11) −0.60 0.558
BDI-IIb 30.86 (16.82) 33.5 (13.91) −0.371 0.716
HAMD-24c 27.86 (9.37) 30.42 (13.87) −0.432 0.671
CTQd
Emotional abuse
Physical abuse
Sexual abuse
Emotional neglect
Physical neglect
Global
16.0 (6.46)
8.57 (7.39)
8.43 (7.46)
16.86 (6.01)
10.43 (4.28)
12.06 (5.61)
19.0 (3.77)
12.58 (7.01)
14.75 (8.66)
18.58 (4.62)
11.17 (4.49)
15.22 (4.43)
−1.29
−1.18
−1.61
−0.70
−0.35
−1.36
0.214
0.253
0.126
0.491
0.730
0.191
RSQe 17.06 (4.46) 18.03 (6.23) −0.36 0.727
Day of menstrual cycle
Hormonal contraception
8.33 (2.81)
3 (42.4%)
10.6 (5.04)
1 (9.1%)
−1.064
X2: 3.273
0.333
0.195
aBSL-23, Borderline Symptom List; bBDI-II, Beck Depression Inventory; cHAMD-24, Hamilton Depression Rating Scale; dCTQ, Childhood Trauma Questionnaire; eRSQ,
Rejection Sensitivity Questionnaire; fSD, standard deviation.
Comparison of cortisol levels between groups
Cortisol plasma levels were analyzed using rmANOVAs as
described above. There were no significant effects of group or
group × time interaction between BPD and HC, BPD patients
with organized and unresolved (disorganized) attachment
representation, and HC with secure and insecure attachment
representation, respectively. There was a significant effect of time:
Cortisol levels significantly decreased in BPD and HC (Jobst
et al., 2014) and this decrease was not influenced by attachment
representation. OT and cortisol plasma levels for all groups and
time points are shown in Table 3.
Psychological Measures during
Cyberball
The results of the psychological measures during Cyberball in
BPD patients and HC have been published elsewhere (Jobst et al.,
2014): To summarize, BPD patients felt more readily excluded,
and the exclusion paradigm had a stronger negative impact on
their needs than it did in HC (Needs-Threat-Questionnaire),
but the social exclusion paradigm did not have impact on inner
tension, neither in BPD, nor in HC. Negative emotions focused
on other significantly increased in BPD (rmANOVA: time effect:
F = 6.065; df = 1; p = 0.019; group effect: F = 14.474; df = 1;
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FIGURE 1 | Differences in baseline plasma OT levels and differences in the changes of plasma levels of OT over time (before and after Cyberball).
*significant at α = 0.05.
p = 0.001; group × time interaction: F = 2.603; df = 1;
p = 0.115). Post hoc t-tests revealed that especially anger and
contempt significantly increased in BPD (anger t = –2.251;
df= 1; p= 0.037; contempt: t= 2.480; df= 18; p= 0.023), which
was not the case in HC (Jobst et al., 2014).
We conducted additional analyses independently for BPD and
HC regarding the association between attachment representation
and psychological reactions toward social exclusion. BPD with
organized and disorganized attachment representations felt
disregarded (t = 0.903; df = 15; p = 0.381) and excluded
(t = 2.095; df = 11.311; p = 0.059) to a comparable degree
and judged ball ownership similarly (t = 0.445; df = 15;
p = 0.663) and realistically (organized: 11.37%; disorganized:
9.85%). Moreover there was no significant difference between
organized and disorganized BPD regarding the aversive impact
triggered by the social exclusion (NTQ aversive impact factor:
t = 0.736; df = 14; p = 0.474). Negative emotions focused on
others increased in both the organized and disorganized group
(rmANOVA: time effect: F = 4.385; df = 1; p = 0.053), but did
not show differences between groups (group effect: F = 0.128
df = 1; p = 0.725) nor a significant group × time interaction
(F = 0.015; df = 1; p = 0.905). However, contempt significantly
increased in the organized group whereas this was not the case
for the disorganized group (rmANOVA: time effect: F = 9.120;
df = 1; p = 0.008; group effect: F = 0.337; df = 1; p = 0.569;
group × time effect: F = 3.446; df = 1; p = 0.082). There
was no such difference for anger. Inner tension did not differ
between groups. Analysis between secure and insecure attached
HC revealed no significant different emotional response to social
exclusion: Both groups felt disregarded (t = 1.065; df = 16;
p = 0.303) and excluded (t = 1.056; df = 16; p = 0.306) to
a comparable degree and judged ball ownership similar (t = –
0.654; df = 16; p = 0.523) and realistically (secure: 8%; insecure
10%). Both groups demonstrated a similarly aversive impact
factor (t = 0.565; df = 16; p = 0.580). Change of other focused
negative emotions and inner tension did not differ between
groups.
DISCUSSION
Insecure and especially unresolved attachment representations
are predominant patterns in patients with BPD. In the present
study, we were able to replicate this finding on a behavioral
level. Our main finding, however was, that BPD patients with
unresolved attachment show significantly lower baseline OT
plasma levels than BPD patients with organized attachment.
These results extend previous findings of lower plasma OT
TABLE 3 | Oxytocin plasma levels in patients with BPD and HC according to attachment representation.
BPD
(n = 19)
HC
(n = 18)
BPD HC
Organized
(n = 7)
Unresolved
(n = 12)
Secure
(n = 8)
Insecure
(n = 10)
Mean (SD)
Oxytocin t1 421.67 (127.70) 450.26 (204.42) 502.14 (130.71) 374.73 (104.11) 443.21 (195.30) 455.89 (221.79)
Oxytocin t2 390.97 (130.70) 471.46 (240.63) 451.73 (186.02) 355.53 (73.21) 451.46 (225.54) 487.56 (263.01)
Oxytocin t3 399.19 (142.60) 468.19 (252.68) 480.60 (175.38) 351.70 (99.09) 466.55 (237.54) 469.50 (276.96)
Oxytocin t4 403.58 (128.54) 454.22 (233.85) 468.36 (133.92) 362.36 (111.91) 456.21 (214.54) 452.62 (259.80)
Cortisol t1 530.04 (236.08) 505.06 (170.52) 635.37 (298.52) 468.60 (188.24) 468.65 (208.98) 454.19 (120.35)
Cortisol t2 522.67 (243.70) 523.87 (185.45) 632.50 (299.91) 458.61 (170.06) 589.81 (223.08) 471.11 (138.41)
Cortisol t3 499.47 (246.31) 497.53 (195.64) 631.53 (312.10) 422.44 (169.03) 563.89 (244.15) 444.44 (137.44)
Cortisol t4 446.24 (221.78) 448.16 (198.26) 554.80 (286.38) 377.16 (144.61) 519.78 (239.67) 390.87 (146.30)
Frontiers in Human Neuroscience | www.frontiersin.org 7 March 2016 | Volume 10 | Article 125
fnhum-10-00125 March 24, 2016 Time: 18:51 # 8
Jobst et al. Oxytocin in Borderline Patients
baseline levels in BPD than in HC and of a negative association
between OT plasma levels and childhood trauma (Bertsch et al.,
2012). The lower OT plasma levels in unresolved attached BPD
seem to be plausible when taking into account that unresolved
attachment trauma is associated with severe childhood trauma
(Stalker and Davies, 1995; Bakermans-Kranenburg and van
IJzendoorn, 2009). Accordingly, in our study BPD patients
with unresolved attachment representations showed significantly
more severe physical and sexual childhood abuse compared to
BPD individuals with organized attachment. In our small sample,
we could not find a direct association between childhood trauma
(CTQ) and OT plasma levels, however, smaller OT recovery was
associated with higher physical and emotional abuse (Jobst et al.,
2014). Therefore it would be of major interest to investigate
in future studies the association between childhood trauma,
unresolved attachment representation, and OT in larger samples
of BPD patients.
Oxytocin change after social exclusion (Cyberball) – a relevant
social stimulus (Williams and Jarvis, 2006; Williams, 2007) that
activates social pain in humans (Eisenberger et al., 2003) –
did not differ in regard to attachment representations (not in
BPD, nor in HC group). Both BPD patients with organized and
those with unresolved attachment representations showed similar
courses of OT after social exclusion; though we found lower
OT plasma levels in BPD patients with unresolved attachment
representations at every time point. Comparing BPD and HC
group, change of OT plasma levels directly after social exclusion
significantly differed as previously described (Jobst et al., 2014):
After social exclusion OT plasma levels tended to decrease in BPD
patients and tended to increase in HC and this different course
was significant. Descriptively OT plasma levels were constantly
lower in BPD patients than in HC. In accordance with other
studies (Zöller et al., 2010; Zwolinski, 2012), the social exclusion
paradigm did not elicit a neurobiological stress reaction, as
central stress pathways might be inhibited due to the presence
of a defensive response (emotional analgesia) (Bass et al., 2014).
Emotional responses to social exclusion differed between
BPD and HC as previously described (Jobst et al., 2014).
Attachment representation did not modify these responses
besides a significant higher increase of contempt in the organized
vs disorganized BPD group. We hypothesize that OT release
after social exclusion might be understood as neuroendocrine
reaction to broken relations. In this context, OT release may
reduce social pain and induce pro-social orientation. In BPD
patients, this OT reaction to social exclusion may be impaired,
possibly corresponding to the general difficulty of BPD patients
in repairing broken cooperation (King-Casas et al., 2008).
In previous studies, BPD patients responded to intranasal
OT administration in the opposite way to HC, i.e., intranasal
OT reduced trust in BPD but increased trust in HC (Bartz
et al., 2011). Moreover, in depressed patients OT administration
in addition to psychotherapy even increased fear during
psychotherapy (Macdonald et al., 2013). Taking these results into
consideration, another hypothesis seems plausible. Reduced OT
levels in BPD as found in our study, and especially in BPD
patients with unresolved attachment representations, might be
the result of an altered OT system, most likely resulting from
early caretaking experiences (Meaney, 2001; Champagne, 2008;
Bertsch et al., 2013; Herpertz and Bertsch, 2015), so that the
patients have a baseline state of “low OT.” Lower OT levels
in BPD compared to HCs might be specifically found in BPD
with unresolved attachment representations but not in BPD
with organized ones. Consequently, this “low OT state” might
represent a protective state in which social pain might be more
bearable, with reduced perception of negative emotions. OT
administration might take the patients out of this state and
consequently increase fear. Experiences occurring in sensitive
periods in early development, especially traumatic childhood
experiences, might critically modify epigenetic states of genes and
influence the developing OT system and according to Kumsta
and Heinrichs (2013) epigenetic modification of genes involved
in OT signaling might therefore be involved in the mechanisms
mediating the long-term influence of early adverse experiences
on socio-behavioral outcomes. In this context the development
of BPD might be understood as a result of early childhood
maltreatment with the development of insecure attachment
representations, which then contribute to Borderline symptoms
in adulthood. This relationship might be neurobiologically
mediated by epigenetic changes, which can be pictured by
changes within the OT system. However, Brüne (2015) suggests
that in the spectrum of childhood trauma, emotional neglect
in early childhood may have a different impact on the OT
system than, e.g., sexual abuse or later traumatic experiences in
adolescence.
Our study has some limitations. These include a small sample
size, pharmacological treatment in the BPD group, especially
intake of neuroleptic medication, and failure to measure estrogen
and progesterone levels. Due to the small sample size and
exploratory character of this study, we did not control for
influencing factors such as medication or depression. This should
be re-analyzed within a larger sample. Moreover, the specificity
of a dysregulated OT system to BPD patients is still unclear, as
well as the interaction of OT with other neuromodulators, such
as the endocannabinoid system, which has been found relevant
for pain processing (Herpertz and Bertsch, 2015). The meaning
and reliability of OT plasma levels with regard to central nervous
system processes is still a matter of debate. Recently published
articles argue that peripheral OT cannot give information about
cognition, emotion and behavior (Meyer-Lindenberg et al., 2011;
Quintana and Woolley, 2015; Leng and Ludwig, 2016; Walum
et al., 2016). However, several studies also state the opposite and
demonstrate an association between peripheral and central OT
measures (Dal Monte et al., 2014; Carson et al., 2015; Freeman
et al., 2016). Future research should clarify this controversy.
Therefore our results have to be interpreted with caution.
Another bias might result from the analysis of OT levels in a non-
extracted plasma sample using a commercially available ELISA,
which limits a direct comparison with other studies that used
extracted samples and radioimmunoassays (Szeto et al., 2011).
In summary, this study demonstrates that BPD patients with
unresolved attachment representations have significantly lower
baseline OT plasma levels than BPD patients with organized
attachment representations. However, this finding needs to be
replicated in a larger sample.
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